101 related articles for article (PubMed ID: 8249700)
21. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
[TBL] [Abstract][Full Text] [Related]
22. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR
Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737
[TBL] [Abstract][Full Text] [Related]
23. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.
Spinelli S; Chiodi S; Costantini S; Van Lint MT; Raiola AM; Ravera GB; Bacigalupo A
Haematologica; 2003 Oct; 88(10):1163-8. PubMed ID: 14555313
[TBL] [Abstract][Full Text] [Related]
24. Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
Greinix HT; Reiter E; Schulenburg A; Keil F; Lechner K; Fischer G; Rosenmayr A; Leitner G; Kalhs P
Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S53-6. PubMed ID: 9916636
[TBL] [Abstract][Full Text] [Related]
25. [Unrelated match bone marrow transplantation for severe aplastic anemia].
Urase F; Ishikawa H; Kanbara M; Hazu S; Tsuji K; Ashida T; Tsubaki K; Horiuchi A
Rinsho Ketsueki; 1993 Dec; 34(12):1584-6. PubMed ID: 8295334
[TBL] [Abstract][Full Text] [Related]
26. Outcome of unrelated bone marrow donor searches in 174 children resulting in 45 patients transplanted in the HLA-matched and -mismatched situation.
Souillet G; Rey S; Bertrand Y; Pujol M; Pondarré C; Bourgeot JP; Raba M; Eljaafari A; Chapuis F; Manel AM; Philippe N; Gebuhrer L
Bone Marrow Transplant; 2000 Jul; 26(1):31-43. PubMed ID: 10918403
[TBL] [Abstract][Full Text] [Related]
27. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
[TBL] [Abstract][Full Text] [Related]
28. Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.
Bunin N; Aplenc R; Iannone R; Leahey A; Grupp S; Monos D; Pierson G
Bone Marrow Transplant; 2005 Feb; 35(4):369-73. PubMed ID: 15640818
[TBL] [Abstract][Full Text] [Related]
29. BMT from unrelated (UD) or family donors other than HLA identical siblings (FDNS), GVHD prophylaxis, incidence and treatment.
Ladenstein R; Peters C; Matthes-Martin S; Rosenmayr A; Höcker P; Pötter R; Pötschinger U; Gadner H
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():86-91. PubMed ID: 8932806
[No Abstract] [Full Text] [Related]
30. Importance of bone marrow cell dose in bone marrow transplantation.
Paulin T
Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow transplantation: the City of Hope experience.
Smith EP; Nademanee A
Clin Transpl; 1995; ():291-310. PubMed ID: 8794275
[TBL] [Abstract][Full Text] [Related]
32. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
King SM; Saunders EF; Petric M; Gold R
Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
[TBL] [Abstract][Full Text] [Related]
33. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Lee KH
Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
[TBL] [Abstract][Full Text] [Related]
35. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Schwinghammer TL; Bloom EJ
Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
[TBL] [Abstract][Full Text] [Related]
37. Donor bone marrow from a sibling with inborn error of metabolism for treatment of acute leukaemia - clinical and biochemical consequences in the non-affected recipient.
Meyer S; Thornley M; Wynn RF; Brennan BM; Carr T; Wraith JE; Will AM
Bone Marrow Transplant; 2000 Apr; 25(8):909-11. PubMed ID: 10808215
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
[TBL] [Abstract][Full Text] [Related]
39. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
[TBL] [Abstract][Full Text] [Related]
40. Successful bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation: long-term follow-up and outcome.
Perkins JL; Neglia JP; Ramsay NK; Davies SM
Bone Marrow Transplant; 2001 Sep; 28(5):523-6. PubMed ID: 11593328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
